Membranoproliferative glomerulonephritis secondary prevention: Difference between revisions
(Created page with "__NOTOC__ Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. {{Membranoproliferative glomerulonephritis...") |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
Overview | |||
Secondary prevention of strategy is a method to reduce the complication of disease, and one of the most important complication of MPGN is end-stage renal disease (ESRD). | |||
Secondary prevention | |||
Risk factors that can predict the progression of the disease to ESRD are included: | |||
* Proteinuria | |||
* Systemic hypertension | |||
* Progressive decline in GFR | |||
When these risk factors have been seen through the natural history of each individual, secondary prevention strategy have been initiate to reduce the chance of ESRD. | |||
Through secondary prevention, these medication should be taken: | |||
* Angiotensin-converting enzyme (ACE) inhibitors | |||
* Angiotensin-receptor blockers | |||
* Combined ACE inhibition and angiotensin receptor antagonism | |||
* Dietary protein restriction | |||
{{Membranoproliferative glomerulonephritis}} | {{Membranoproliferative glomerulonephritis}} | ||
| Line 8: | Line 24: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Nephrology]] | [[Category:Nephrology]] | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
Revision as of 03:27, 26 July 2018
Overview
Secondary prevention of strategy is a method to reduce the complication of disease, and one of the most important complication of MPGN is end-stage renal disease (ESRD).
Secondary prevention
Risk factors that can predict the progression of the disease to ESRD are included:
- Proteinuria
- Systemic hypertension
- Progressive decline in GFR
When these risk factors have been seen through the natural history of each individual, secondary prevention strategy have been initiate to reduce the chance of ESRD.
Through secondary prevention, these medication should be taken:
- Angiotensin-converting enzyme (ACE) inhibitors
- Angiotensin-receptor blockers
- Combined ACE inhibition and angiotensin receptor antagonism
- Dietary protein restriction
|
Membranoproliferative glomerulonephritis Microchapters |
|
Differentiating Membranoproliferative glomerulonephritis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Membranoproliferative glomerulonephritis secondary prevention On the Web |
|
American Roentgen Ray Society Images of Membranoproliferative glomerulonephritis secondary prevention |
|
FDA on Membranoproliferative glomerulonephritis secondary prevention |
|
CDC on Membranoproliferative glomerulonephritis secondary prevention |
|
Membranoproliferative glomerulonephritis secondary prevention in the news |
|
Blogs on Membranoproliferative glomerulonephritis secondary prevention |
|
Directions to Hospitals Treating Membranoproliferative glomerulonephritis |
|
Risk calculators and risk factors for Membranoproliferative glomerulonephritis secondary prevention |